About US
Contact us
-
Associated Press examines Chinese vaccine makers' entry into international market"China's vaccine makers are gearing up over the next few years to push exports in a move that should lower costs of lifesaving immunizations for the world's poor and provide major new competition for2011/12/1
-
SFDA Commissioner Shao Mingli attends the signing ceremony of Cooperation Agreement for Establishing Hong Kong's Chinese Crude Drugs Standards between NIFDC and Hong Kong Department of HealthOn the afternoon of November 22, 2011, Li Yunlong, Director of National Institutes for Food and Drug Control (NIFDC), and Dr. P.Y. LAM, Director of Health of the Government of the Hong Kong Special Ad2011/12/1
-
Guiding Opinions on Accelerating the Construction of the Monitoring System of Cosmetic Adverse Reactions issuedIn order to speed up the construction of the monitoring system of cosmetic adverse reactions, strengthen the monitoring and evaluation of cosmetic adverse reactions and safeguard the consumer’s health2011/12/1
-
SFDA Commissioner Shao Mingli met Swedish Minister for Children and the Elderly and signed bilateral MOUOn the afternoon of November 23, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Ms. Maria Larsson, Minister for Children and the Elderly, Minis2011/12/1
-
AZ bolsters VC arm with $100 million, buys into Australian firmAstraZeneca has committed an additional $100 million to its venture capital arm and announced an investment in Australian life sciences start-up NeuProtect. The Anglo-Swedish drugmaker's MedImmune2011/11/30
-
EU OK for Komboglyze, expanded use for OnglyzaAstraZeneca and Bristol-Myers Squibb are celebrating after regulators in Europe gave approvals for two of their diabetes drugs. First up, European Commission has granted marketing authorisation for2011/11/30
-
Hospital-treated infections market to exceed $4bn by 2020The market for drugs used for hospital-treated infections such as MRSA will increase to over $4bn by 2020, according to forecasts produced by Decision Resources. Although there is increased competi2011/11/30
-
Novartis submits NVA237 for Japanese approvalNovartis has submitted NVA237, the company's new treatment for chronic obstructive pulmonary disease, for approval in Japan. The drug, which was submitted for European approval in September 2011 unde2011/11/29
-
Merck to send water test kits to flood-hit ThailandMerck has sent thousands of water test kits to flood-hit Thailand in an effort to safeguard the quality of drinking water and prevent the spread of waterborne diseases. The company's Merck Millipore2011/11/29
-
Pfizer to buy Excaliard PharmaceuticalsPfizer has entered into a definitive agreement to acquire Excaliard Pharmaceuticals, gaining access to EXC 001, a skin scarring treatment. Co-developed by Excaliard and Isis Pharmaceuticals, EXC 0012011/11/28